Publikationen in Zusammenarbeit mit Forschern von Hospital Ramón y Cajal (9)

2023

  1. Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution

    Frontiers in Immunology, Vol. 14

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2019

  1. Tendothelial extracellular vesicles produced by senescent cells: Pathophysiological role in the cardiovascular disease associated with all types of diabetes mellitus

    Current Vascular Pharmacology, Vol. 17, Núm. 5, pp. 447-454

2007

  1. Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients

    Human Mutation, Vol. 28, Núm. 6, pp. 613-621

2005

  1. Brief report: Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma

    Journal of Clinical Endocrinology and Metabolism, Vol. 90, Núm. 4, pp. 2127-2130

2003

  1. VIP and PACAP receptors coupled to adenylyl cyclase in human lung cancer: A study in biopsy specimens

    Peptides, Vol. 24, Núm. 3, pp. 429-436

2002

  1. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma

    European Journal of Human Genetics, Vol. 10, Núm. 8, pp. 457-461

2000

  1. Immunohistochemical and immunochemical evidence for expression of human lung PACAP/VIP receptors

    Annals of the New York Academy of Sciences

  2. Immunohistochemical localization and distribution of VIP/PACAP receptors in human lung

    Peptides, Vol. 21, Núm. 2, pp. 265-269